Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 3, 2026
Sale
Shares
6,195
Price
$42.84
Total Value
$265.41K
Shares Held After
23,972
% of Holdings
20.5%
Feb 3, 2026
Sale
Shares
108,759
Price
$42.84
Total Value
$4.66M
Shares Held After
183,656
% of Holdings
37.2%

Karyopharm Therapeutics Inc. (KPTI)

Macomber Lori — EVP, CFO & Treasurer
Feb 3, 2026
Sale
Shares
1,626
Price
$6.30
Total Value
$10.24K
Shares Held After
85,105
% of Holdings
1.9%

Hims & Hers Health, Inc. (HIMS)

Okupe Oluyemi — Chief Financial Officer
Feb 3, 2026
Sale
Shares
5,262
Price
$26.44
Total Value
$139.11K
Shares Held After
91,617
% of Holdings
5.4%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Feb 3, 2026
Sale
Shares
795
Price
$155.77
Total Value
$123.84K
Shares Held After
84,112
% of Holdings
0.9%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 3, 2026
Sale
Shares
640
Price
$156.27
Total Value
$100.01K
Shares Held After
56,397
% of Holdings
1.1%

INSMED Inc (INSM)

Lewis William — Director
Feb 3, 2026
Sale
Shares
3,009
Price
$156.34
Total Value
$470.43K
Shares Held After
303,882
% of Holdings
1.0%

INSMED Inc (INSM)

Bonstein Sara — Chief Financial Officer
Feb 3, 2026
Sale
Shares
748
Price
$156.34
Total Value
$116.94K
Shares Held After
79,758
% of Holdings
0.9%

INSMED Inc (INSM)

Adsett Roger — Chief Operating Officer
Feb 3, 2026
Sale
Shares
791
Price
$156.17
Total Value
$123.53K
Shares Held After
106,810
% of Holdings
0.7%

CareDx, Inc. (CDNA)

Novack Jeffrey Adam — Secretary and General Counsel
Feb 3, 2026
Sale
Shares
4,441
Price
$20.56
Total Value
$91.29K
Shares Held After
125,364
% of Holdings
3.4%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Feb 3, 2026
Sale
Shares
7,175
Price
$32.12
Total Value
$230.46K
Shares Held After
108,205
% of Holdings
6.2%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Feb 3, 2026
Sale
Shares
12,446
Price
$32.87
Total Value
$409.10K
Shares Held After
109,087
% of Holdings
10.2%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Feb 3, 2026
Sale
Shares
4,333
Price
$32.12
Total Value
$139.18K
Shares Held After
49,080
% of Holdings
8.1%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — CHIEF COMMERCIAL OFFICER
Feb 3, 2026
Sale
Shares
7,310
Price
$32.12
Total Value
$234.80K
Shares Held After
131,823
% of Holdings
5.3%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Feb 3, 2026
Sale
Shares
7,242
Price
$32.12
Total Value
$232.61K
Shares Held After
112,971
% of Holdings
6.0%
Feb 3, 2026
Sale
Shares
33,635
Price
$32.70
Total Value
$1.10M
Shares Held After
432,886
% of Holdings
7.2%
Feb 3, 2026
Sale
Shares
66,452
Price
$32.06
Total Value
$2.13M
Shares Held After
466,521
% of Holdings
12.5%

Travere Therapeutics, Inc. (TVTX)

Inrig Jula — CHIEF MEDICAL OFFICER
Feb 3, 2026
Sale
Shares
6,956
Price
$32.12
Total Value
$223.43K
Shares Held After
107,485
% of Holdings
6.1%
Shares
27,500
Price
$4.24
Total Value
$116.64K
Shares Held After
49,000
% of Holdings
35.9%
Feb 3, 2026
Purchase
Shares
2,177
Price
$21.94
Total Value
$47.76K
Shares Held After
641,682
% of Holdings
0.3%
Feb 3, 2026
Purchase
Shares
2,178
Price
$21.94
Total Value
$47.79K
Shares Held After
641,685
% of Holdings
0.3%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Feb 3, 2026
Purchase
Shares
2,500
Price
$1.38
Total Value
$3.45K
Shares Held After
115,190
% of Holdings
2.2%
Feb 3, 2026
Sale
Shares
50
Price
$474.23
Total Value
$23.71K
Shares Held After
270
% of Holdings
15.6%
Feb 2, 2026
Sale
Shares
266,290
Price
$0.01
Total Value
$3.86K
Shares Held After
25,126,710
% of Holdings
1.0%

WEED, INC. (BUDZ)

BREEN NICOLE M — Director
Feb 2, 2026
Sale
Shares
31,625
Price
$0.04
Total Value
$1.11K
Shares Held After
30,381,968
% of Holdings
0.1%

Spero Therapeutics, Inc. (SPRO)

Keutzer Timothy — Chief Operating Officer
Feb 2, 2026
Sale
Shares
18,891
Price
$2.20
Total Value
$41.56K
Shares Held After
788,853
% of Holdings
2.3%

Spero Therapeutics, Inc. (SPRO)

Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Feb 2, 2026
Sale
Shares
18,442
Price
$2.20
Total Value
$40.57K
Shares Held After
1,100,008
% of Holdings
1.6%
Feb 2, 2026
Sale
Shares
7,039
Price
$18.02
Total Value
$126.84K
Shares Held After
358,234
% of Holdings
1.9%
Feb 2, 2026
Sale
Shares
14,043
Price
$32.87
Total Value
$461.59K
Shares Held After
657,540
% of Holdings
2.1%
Feb 2, 2026
Sale
Shares
957
Price
$31.82
Total Value
$30.45K
Shares Held After
671,583
% of Holdings
0.1%
Feb 2, 2026
Sale
Shares
100
Price
$234.00
Total Value
$23.40K
Shares Held After
127,881
% of Holdings
0.1%
Feb 2, 2026
Sale
Shares
7,445
Price
$233.31
Total Value
$1.74M
Shares Held After
127,981
% of Holdings
5.5%
Feb 2, 2026
Sale
Shares
9,197
Price
$232.41
Total Value
$2.14M
Shares Held After
135,426
% of Holdings
6.4%
Feb 2, 2026
Sale
Shares
20,079
Price
$230.95
Total Value
$4.64M
Shares Held After
144,623
% of Holdings
12.2%
Feb 2, 2026
Sale
Shares
41,847
Price
$230.03
Total Value
$9.63M
Shares Held After
164,702
% of Holdings
20.3%
Feb 2, 2026
Sale
Shares
6,631
Price
$229.08
Total Value
$1.52M
Shares Held After
206,549
% of Holdings
3.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
16
Price
$234.00
Total Value
$3.74K
Shares Held After
139,486
% of Holdings
0.0%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
600
Price
$233.24
Total Value
$139.94K
Shares Held After
139,502
% of Holdings
0.4%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
850
Price
$232.33
Total Value
$197.48K
Shares Held After
140,102
% of Holdings
0.6%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
576
Price
$230.84
Total Value
$132.96K
Shares Held After
140,952
% of Holdings
0.4%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
878
Price
$229.96
Total Value
$201.90K
Shares Held After
141,528
% of Holdings
0.6%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
80
Price
$228.50
Total Value
$18.28K
Shares Held After
142,406
% of Holdings
0.1%
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
231,138
% of Holdings
0.0%
Shares
100
Price
$3.07
Total Value
$307.00
Shares Held After
231,238
% of Holdings
0.0%
Shares
10
Price
$3.05
Total Value
$30.50
Shares Held After
231,338
% of Holdings
0.0%
Shares
90
Price
$3.05
Total Value
$274.50
Shares Held After
231,348
% of Holdings
0.0%
Shares
100
Price
$3.07
Total Value
$307.00
Shares Held After
231,438
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
231,538
% of Holdings
0.0%
Shares
100
Price
$3.06
Total Value
$306.00
Shares Held After
231,588
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
231,688
% of Holdings
0.0%
Version: v26.3.33